₹ 14868 / 14 Shares Shares
Minimum Investment
₹1008-1062 per equity share
08 Dec 2025
10 Dec 2025
14
₹ 14868
₹1008-1062
15 Dec 2025
61,71,101 shares(aggregating up to ₹655.37 crore)
₹10 Per Equity Share
14 Shares
14 Shares
Incorporated in August 2004, Corona Remedies Limited is a pharmaceutical company developing, manufacturing, and marketing products in women's healthcare, cardiology, pain management, urology, and other therapeutic areas. The diversified portfolio of the company as of December 2024 comprises 67 brands across therapeutic areas such as women's healthcare, cardio-diabeto, pain management, urology, and multispecialty pharmaceuticals, including vitamins/minerals/nutrition, gastrointestinal, and respiratory.The company has a pan-India marketing and distribution network with 2,598 medical representatives in 22 states, enabling effective engagement with healthcare professionals and hospitals, thus consolidating its presence in the IPM and ensuring deep penetration in therapeutic areas. Presently, the company owns two manufacturing facilities located in the states of Gujarat. As of December 31, 2024, the company had 88 R&D employees.
2004
Dr. Kirtikumar Laxmidas Mehta
Corona Remedies Limited IPO
| Apply as | Price Range | Apply Upto |
|---|---|---|
| Retail (min) | ₹1008-1062 | ₹14,868 |
| Retail(max) | ₹1008-1062 | ₹1,93,284 |
| SHNI(min) | ₹1008-1062 | ₹2,08,152 |
| SHNI(max) | ₹1008-1062 | ₹9,96,156 |
| BHNI(min) | ₹1008-1062 | ₹10,11,024 |
For Corona Remedies Limited IPO, eligible investors can apply as Regular.
Yes, KSquare offers ELSS mutual funds, which are eligible for tax deductions under Section 80C up to ₹1.5 lakh.
Partial withdrawals of up to 25% are allowed after 3 years for specific purposes like medical emergencies, education, or house purchase.
NFOs can be suitable for beginners, but they carry risks. KSquare helps assess fund strategies before you commit.
Basic KYC documents, bank statements, and demat account details are required. KSquare helps with digital submission.
You can typically borrow up to 50–70% of your mutual fund’s NAV value. KSquare calculates this during your application.
Yes, NPS invests in equity and debt instruments, so returns vary with market performance over time.
NRIs need either an NRE or NRO account to start investing through KSquare, depending on fund repatriation needs.
Some SIP funds offer liquidity options, allowing partial withdrawals whenever required without disturbing the entire investment plan.
Ksquare Timeline Pvt. Ltd. is an AMFI Registered Mutual Fund Distributor having ARN No. 146262. Mutual Fund investments are subject to market risks. Please read all scheme related documents carefully before investing. This website is intended only for informational and self-help purposes and should not be considered as investment advice or return guarantee. Past performance is not indicative of future results. Terms & Conditions apply.